C3d enhancement of neutralizing antibodies to measles hemagglutinin (Q40778956)

23 September 2017

C3d enhancement of neutralizing antibodies to measles hemagglutinin (English)

1 reference

23 September 2017

1 reference

1 reference

3

Rota PA

1 reference

23 September 2017

Green TD

1

1 reference

23 September 2017

Newton BR

2

1 reference

23 September 2017

Xu Y

4

1 reference

23 September 2017

Robinson HL

5

1 reference

23 September 2017

Ross TM

6

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

23 September 2017

1 reference

23 September 2017

20

1 reference

23 September 2017

1-2

1 reference

23 September 2017

242-248

1 reference

Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months.

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

DNA vaccines for viral infections: basic studies and applications

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

Early studies on DNA-based immunizations for measles virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

Measles virus DNA vaccination: antibody isotype is determined by the method of immunization and by the nature of both the antigen and the coimmunized antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

Class I-restricted CTL induction by mucosal immunization with naked DNA encoding measles virus haemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

C3d of complement as a molecular adjuvant: bridging innate and acquired immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

DNA immunization: effect of secretion of DNA-expressed hemagglutinins on antibody responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

Studies on antibody responses following neonatal immunization with influenza hemagglutinin DNA or protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

Establishment and characterisation of murine cells constitutively expressing the fusion, nucleoprotein and matrix proteins of measles virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

Role of virus strain dm conventional and enhanced measles plaque neutralization test

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

Measles antibody: reevaluation of protective titers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

The complement system and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

Live measles vaccine: a 21 year follow up.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

DNA vaccines for influenza virus: differential effects of maternal antibody on immune responses to hemagglutinin and nucleoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

DNA immunization of neonates induces immunity despite the presence of maternal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

Effective priming of neonates born to immune dams against the immunogenic pseudorabies virus glycoprotein gD by replication-incompetent adenovirus-mediated gene transfer at birth

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900266-3

7 January 2021

10.1016/S0264-410X(01)00266-3

Identifiers

DOI

1 reference

23 September 2017

1 reference